المؤلفون: Fengmei Lian, De Jin, Wenjing Huang, Meizhen Zhang, Qi Bao, Xiang Meng, Xiaolin Tong, Fan Yang, Qing Ni, Ya-nan Yang

المصدر: Trials
Trials, Vol 20, Iss 1, Pp 1-8 (2019)

مصطلحات موضوعية: Male, Medicine (miscellaneous), Type 2 diabetes, Kidney, law.invention, Placebos, chemistry.chemical_compound, Study Protocol, 0302 clinical medicine, Randomized controlled trial, law, Prevalence, Pharmacology (medical), Diabetic Nephropathies, Medicine, Chinese Traditional, lcsh:R5-920, 0303 health sciences, Proteinuria, Middle Aged, Treatment Outcome, 030220 oncology & carcinogenesis, Female, medicine.symptom, lcsh:Medicine (General), Glomerular Filtration Rate, Adult, medicine.medical_specialty, China, Renal function, Placebo, Losartan, 03 medical and health sciences, Traditional Chinese medicine, Double-Blind Method, Internal medicine, medicine, Albuminuria, Humans, Diabetic kidney disease, Antihypertensive Agents, 030304 developmental biology, Aged, Creatinine, business.industry, medicine.disease, Treatment, Early Diagnosis, chemistry, Case-Control Studies, Microalbuminuria, business, Kidney disease, Drugs, Chinese Herbal

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21cf20f9bb4f96fe86a80b8045fe2b54
http://europepmc.org/articles/PMC6925411